drugset / Trial / NCT00266630
Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The efficacy and safety of the extended treatment to patients with most recent episode manic or mixed who completed previous double blind study (F1D-JE-BMAC \[Study BMAC\]) will be examined.
Timeline
- Start
- 2005-11
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | 5 mg | Oral |
| Subject | Olanzapine | Small molecule | 20 mg | Oral |
| Background | Carbamazepine | Small molecule | — | — |
| Background | Lithium | Unknown | — | — |
| Background | Valproate | Small molecule | — | — |